Source:http://linkedlifedata.com/resource/pubmed/id/17237715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-22
|
pubmed:abstractText |
Insulin-like growth factor binding protein (IGFBP)-3 binds to IGF and modulates their actions and also possesses intrinsic activities. We investigated its effects on insulin action and found that when IGFBP-3 was added to fully differentiated 3T3-L1 adipocytes in culture, insulin-stimulated glucose transport was significantly inhibited to 60% of control in a time- and dose-dependent manner. Tumor necrosis factor (TNF)-alpha treatment also inhibited glucose transport to the same degree as IGFBP-3 and, in addition, increased IGFBP-3 levels 3-fold. Co-treatment with TNF-alpha and IGFBP-3 antisense partially prevented the inhibitory effect of TNF-alpha on glucose transport, indicating a role for IGFBP-3 in cytokine-induced insulin resistance. Insulin-stimulated phosphorylation of the insulin receptor was markedly decreased by IGFBP-3 treatment. IGFBP-3 treatment suppressed adiponectin expression in 3T3-L1 adipocytes. Infusion of IGFBP-3 to Sprague-Dawley rats for 3 h decreased peripheral glucose uptake by 15% compared with controls as well as inhibiting glycogen synthesis. Systemic administration of IGFBP-3 to rats for 7 d resulted in a dramatic 40% decrease in peripheral glucose utilization and glycogen synthesis. These in vitro and in vivo findings demonstrate that IGFBP-3 has potent insulin-antagonizing capability and suggest a role for IGFBP-3 in cytokine-induced insulin resistance and other mechanisms involved in the development of type-2 diabetes.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/P01-AG021654,
http://linkedlifedata.com/resource/pubmed/grant/P30DK063491,
http://linkedlifedata.com/resource/pubmed/grant/P50CA92131,
http://linkedlifedata.com/resource/pubmed/grant/R01AG20954,
http://linkedlifedata.com/resource/pubmed/grant/R01HD047013
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0031-3998
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:17237715-3T3-L1 Cells,
pubmed-meshheading:17237715-Adipocytes,
pubmed-meshheading:17237715-Adiponectin,
pubmed-meshheading:17237715-Animals,
pubmed-meshheading:17237715-Glucose,
pubmed-meshheading:17237715-Humans,
pubmed-meshheading:17237715-Insulin Resistance,
pubmed-meshheading:17237715-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:17237715-Mice,
pubmed-meshheading:17237715-Phosphorylation,
pubmed-meshheading:17237715-Rats,
pubmed-meshheading:17237715-Rats, Sprague-Dawley,
pubmed-meshheading:17237715-Receptor, Insulin,
pubmed-meshheading:17237715-Recombinant Fusion Proteins,
pubmed-meshheading:17237715-Tumor Necrosis Factor-alpha
|
pubmed:year |
2007
|
pubmed:articleTitle |
Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo.
|
pubmed:affiliation |
Department of Pediatrics, Ewha Womans University, Seoul, 120-750 Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|